Human medicinal products
SPC PL
Veterinary medicinal
products
SPC PL
Herbal medicinal products
SPC PL
Name of the medicinal
product
A B C D E F G
H I J K L M N
O P Q R S T U
V W X Y Z Å Ä Ö
Name of the medicinal
product

Marketing authorisation
holder

Marketing authorisation
number

ATC Code Codes

Free text search

Active agent

Pharmaceutical form

Adverse effect

Therapeutic indication

Contraindication

Insert text in the fields in Finnish


Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.


Summaries of Product Characteristics 361 - 390 of 447
Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  |  Next 30   >    
Package
leaflet
Status for
supply
Name of the medicinal product

European Medicines Agency's website:
Atazanavir Krka - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Atazanavir Mylan - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Atazanavir Stada 200 mg, 300 mg kapseli, kova SPC 2023-12-14

European Medicines Agency's website:
Atectura Breezhaler - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Atenativ infuusiokuiva-aine ja liuotin, liuosta varten SPC 2021-11-29

PL

Resepti

Atenblock 25 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2023-11-24 Uusi

PL

Resepti

Atenolol Sandoz 25 mg, 50 mg tabletti SPC 2021-03-23

PL

Resepti

Atenolol Sandoz 25 mg, 50 mg tabletti SPC 2021-03-23

PL

Resepti

Atgam 50 mg-ml infuusiokonsentraatti, liuosta varten SPC 2023-10-03

PL

Resepti

Atomoxetin Orion 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, 100 mg kapseli, kova SPC 2023-08-16

PL

Resepti

Atomoxetine Accord 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, 100 mg SPC 2021-12-17

PL

Resepti

Atomoxetine Stada 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg kapseli, kova SPC 2020-04-30

PL

Resepti

Atorbir 10 mg, 20 mg, 40 mg tabletti, kalvopäällysteinen SPC 2024-01-22

PL

Resepti

Atorvastatin Accord 10 mg, 20 mg, 40 mg, 80 mg tabletti, kalvopäällysteinen SPC 2023-03-21

PL

Resepti

Atorvastatin Krka 10 mg, 20 mg, 40 mg tabletti, kalvopäällysteinen SPC 2023-03-08

PL

Resepti

Atorvastatin Krka 80 mg tabletti, kalvopäällysteinen SPC 2023-03-08

PL

Resepti

Atorvastatin Orion 10 mg, 20 mg, 40 mg, 80 mg tabletti SPC 2023-11-07

PL

Resepti

Atorvastatin Orion Pharma 10 mg, 20 mg, 40 mg, 80 mg tabletti, kalvopäällysteinen SPC 2023-03-07

PL

Resepti

Atorvastatin ratiopharm 10 mg, 20 mg, 40 mg, 80 mg tabletti, kalvopäällysteinen SPC 2023-03-22

PL

Resepti

Atorvastatin Viatris 10 mg, 20 mg, 40 mg 80 mg tabletti, kalvopäällysteinen SPC 2023-05-08

PL

Resepti

Atosiban Accord 37,5 mg-5 ml infuusiokonsentraatti, liuosta varten SPC 2022-03-07

PL

Resepti

Atosiban Accord 6,75 mg injektioneste, liuos esitäytetty ruisku SPC 2022-03-22

PL

Resepti

Atosiban EVER Pharma 37.5mg-5ml infuusiokonsentraatti-liuosta varten SPC 2020-04-03

PL

Resepti

Atosiban EVER Pharma 6.75mg-0.9ml injektioneste-liuos SPC 2020-04-03

PL

Resepti

Atosiban EVER Pharma 75mg-10ml infuusiokonsentraatti-liuosta varten SPC 2020-04-03

European Medicines Agency's website:
Atosiban SUN - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Atriance - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Atrodual sumutinliuos SPC 2020-01-31

PL

Resepti

Atropin 1 mg-ml injektioneste, liuos SPC 2023-02-01

PL

Resepti

Atropin Abboxia 0,5 mg-ml, 1 mg-ml injektioneste, liuos, SPC 2024-01-18

Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  |  Next 30   >